文献速递角膜与眼表疾病

在圆锥角膜穿透性角膜移植术中使用经角膜胶原交联预处理的供体

Use of Donors Predisposed by Corneal Collagen Cross-linking in Penetrating Keratoplasty for Treating Patients With Keratoconus.
PubMed 文献 · Am J Ophthalmol · 2017-10-13

这项随机对照试验将116只圆锥角膜眼分配至CXL预处理供体组或常规供体组,比较穿透性角膜移植术后视力与屈光地形图指标。随访3年时,CXL供体组CDVA、等效球镜、散光及地形图参数均优于常规供体组。

要点

  • CXL预处理供体组术后1年起UDVA与CDVA优于常规供体组。
  • 3年时CXL组等效球镜-3.50±2.93D vs 常规组-4.02±2.57D(P=.034)。
  • CXL组柱镜、Kmax、角膜屈光力及角膜散光均低于常规组。

核心结论

  • 使用CXL预处理供体可降低圆锥角膜穿透性角膜移植术后的地形图读数,从而减少近视性屈光误差并提高视力。

研究设计与样本

  • 随机对照试验,纳入中山眼科中心116例圆锥角膜患者的116只眼,采用分层区组随机化分为CXL供体组(第1组)和常规供体组(第2组),比较术后12、24、36个月数据。

主要发现

  • 术后1年随访,第1组UDVA和CDVA优于第2组。
  • 术后1年随访,第1组等效球镜度数和显性柱镜均低于第2组。
  • 3年随访时,第1组CDVA为0.17±0.10 logMAR,第2组为0.23±0.12 logMAR(P=.004)。
  • 3年随访时,第1组等效球镜为-3.50±2.93 D,第2组为-4.02±2.57 D(P=.034);第1组显性柱镜为-5.22±2.64 D,第2组为-6.35±2.80 D(P=.013)。
  • 3年随访时,第1组与第2组比较:Kmax为46.85±2.85 D vs 49.37±2.92 D(P=.036),角膜屈光力为44.41±2.89 D vs 46.35±2.87 D(P=.001),角膜散光为4.53±1.06 D vs 5.98±1.28 D(P<.001)。

关键数值与推荐

  • CXL供体组3年CDVA 0.17±0.10 logMAR vs 常规供体组0.23±0.12 logMAR(P=.004)。
  • CXL供体组3年等效球镜-3.50±2.93 D vs 常规供体组-4.02±2.57 D(P=.034)。
  • CXL供体组3年显性柱镜-5.22±2.64 D vs 常规供体组-6.35±2.80 D(P=.013)。
  • CXL供体组3年Kmax 46.85±2.85 D vs 常规供体组49.37±2.92 D(P=.036)。
  • CXL供体组3年角膜屈光力44.41±2.89 D vs 常规供体组46.35±2.87 D(P=.001);角膜散光4.53±1.06 D vs 5.98±1.28 D(P<.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To investigate whether use of donors predisposed by corneal collagen cross-linking (CXL) reduced myopic refractive errors for keratoconic eyes after penetrating keratoplasty (PK). DESIGN: Randomized controlled trial. METHODS: One hundred sixteen eyes of 116 patients with keratoconus from Zhongshan Ophthalmic Center were enrolled. Using stratified block randomization, we assigned eligible eyes to the CXL graft group (Group 1) or conventional graft group (Group 2). Uncorrected distance visual acuity (UDVA), corrected distance visual acuity (CDVA), spherical equivalent (SE), and topographic data were compared 12, 24, and 36 months after surgery. RESULTS: Group 1 had better UDVA and CDVA than Group 2 after 1 year follow-up. Also, Group 1 had a lesser degree of SE and lower manifest cylinder than Group 2. At 3 years follow-up, mean CDVA was 0.17 ± 0.10 logarithm of the minimum angle of resolution (logMAR) in Group 1 vs 0.23 ± 0.12 logMAR in Group 2 (P = .004). Mean SE was -3.50 ± 2.93 diopter (D) in Group 1 and -4.02 ± 2.57 D in Group 2 (P = .034). Mean manifest cylinder was -5.22 ± 2.64 D and -6.35 ± 2.80 D in Group 1 and Group 2, respectively (P = .013). At 3 years follow-up, simulated keratometry in the steepest meridian (Kmax) was 46.85 ± 2.85 D vs 49.37 ± 2.92 D (P = .036); corneal power was 44.41 ± 2.89 D vs 46.35 ± 2.87 D (P = .001); and keratometric astigmatism was 4.53 ± 1.06 D vs 5.98 ± 1.28 D (P < .001) in Group 1 and Group 2, respectively. CONCLUSIONS: Use of donors predisposed by CXL could reduce topographic readings after PK for the treatment of keratoconus, and consequently reduce myopic refractive errors and improve visual acuity.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Huang T, Ye R, Ouyang C, et al. Use of Donors Predisposed by Corneal Collagen Cross-linking in Penetrating Keratoplasty for Treating Patients With Keratoconus. Am J Ophthalmol. 2017. PMID: 29032110. doi:10.1016/j.ajo.2017.10.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。